Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06571383 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss

StatusActive, Not Recruiting
PhasePhase 4
Started2024-09-17
View on ClinicalTrials.gov ↗
The study is testing how well semaglutide can help adolescents with excess body weight to lose weight and to maintain weight loss. All participants in the study will receive semaglutide as a weekly injection. The study medicine is injected with a thin needle in the stomach, thighs or upper arms. All participants will get semaglutide treatment for a minimum of 3 years.

Amendment record

Amended 27 times since 2024-08-22; most recent filed 2026-06-01. Every amendment is listed below.

Dates here are the day the sponsor filed the amendment, not the day ClinicalTrials.gov published it. Version history last read from ClinicalTrials.gov on 2026-08-30.

2026-06-01
Amendment Study Status, Contacts/Locations v27
2025-12-16
Amendment Study Status, Contacts/Locations v26
2025-11-06
Amendment Study Status, Contacts/Locations v25
2025-10-30
Amendment Recruiting→Active, Not Recruiting Study Status, Contacts/Locations v24
2025-10-20
Amendment Study Status, Contacts/Locations v23
2025-09-18
Amendment Study Status, Contacts/Locations v22
2025-09-01
Amendment Study Status, Contacts/Locations v21
2025-08-08
Amendment Study Status, Contacts/Locations v20
2025-07-02
Amendment Study Status, Contacts/Locations v19
2025-06-04
Amendment Study Status, Contacts/Locations v18
2025-05-21
Amendment Study Status, Contacts/Locations v17
2025-05-07
Amendment Study Status, Contacts/Locations v16
2025-04-09
Amendment Study Status, Outcome Measures, Contacts/Locations v15
2025-03-13
Amendment Study Status, Contacts/Locations v14
2025-03-11
Amendment Study Status, Contacts/Locations v13
2025-02-07
Amendment Study Status, Contacts/Locations v12
2025-01-20
Amendment Study Status v11
2024-12-19
Amendment Study Status, Contacts/Locations v10
2024-11-11
Amendment Study Status, Contacts/Locations v9
2024-10-24
Amendment Study Status, Contacts/Locations v8
2024-10-08
Amendment Study Status, Contacts/Locations v7
2024-10-02
Amendment Study Status, Contacts/Locations v6
2024-09-26
Amendment Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v5
2024-09-13
Amendment Study Status, Contacts/Locations v4
2024-09-10
Amendment Study Status, Contacts/Locations v3
2024-09-05
Amendment Study Status, Contacts/Locations v2
2024-08-28
Amendment Study Status, Contacts/Locations v1
2024-08-22
Original filing
Trial Details
NCT Number NCT06571383
Lead Sponsor Novo Nordisk A/S
Conditions Obesity
Enrollment 500 participants
Start Date 2024-09-17
Primary Completion 2028-11-15 (estimated)
Study Completion 2031-11-15 (estimated)
Updated on ClinicalTrials.gov 2026-06-02